Article
Engineering human prolactin to bind to the human growth hormone receptor.
Science (New York, N.Y.) - 23 Mar 1990
Cunningham B C, Henner D J, Wells J A
Abstract excerpt
A strategy of iterative site-directed mutagenesis and binding analysis was used to incorporate the receptor-binding determinants from human growth hormone (hGH) into the nonbinding homolog, human prolactin (hPRL). The complementary DNA for hPRL was cloned, expressed in Escherichia coli, and mutated to introduce sequentially those substitutions from hGH that were predicted by alanine-scanning mutagenesis and other...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
